Exova Group PLC Directorate Change (3770X)
August 28 2015 - 2:02AM
UK Regulatory
TIDMEXO
RNS Number : 3770X
Exova Group PLC
28 August 2015
Exova Group plc
Notification of board changes
Exova Group plc ("Exova") today announces the following changes
to its board of directors:
-- Fred Kindle is planning to stand down as Non-Executive
Chairman with effect from 1 January 2016. He will continue as a
Non-Executive Director on the Exova board. Fred became a
Non-Executive Director of Exova in 2008 and is a partner of
Clayton, Dubilier & Rice, the company's largest
shareholder.
-- Allister Langlands, currently Exova's Senior Independent
Director, will replace Fred as Non-Executive Chairman. Allister
became Senior Independent Director of Exova upon the company's IPO
on 14 April 2014. Allister was with John Wood Group plc from 1991
until 2014 and held a number of positions including being Group CEO
from 2007 before becoming Chairman from 2012 until 2014. He is
currently the Chairman of Maven Income & Growth VCT 5 plc and a
Non-Executive Director of WS Atkins plc and Standard Life UK
Smaller Companies Trust plc.
-- Exova plans to appoint a new Senior Independent Director over the coming months.
-- Anne Thorburn, who has been Chief Financial Officer ("CFO")
since 2009, has indicated her intention to retire during 2016.
Exova has commenced a process to recruit her successor and Anne
will continue as CFO to enable a full handover. The announcement of
Anne's successor will be made in due course.
Commenting on today's announcement, Fred Kindle, Chairman, said:
"I am delighted that Allister will be taking over my position as
Chairman of the board. He is very well qualified to take on this
role and, with this change, the Chairman of Exova will be
independent of its largest shareholder for corporate governance
purposes. I would also like to take this opportunity to thank Anne
for her hard work, dedication and very considerable contribution to
the business and the board over the past six years."
There are no other matters relating to the changes to the board
which would require disclosure under LR 9.6.11R.
For further information please contact:
Ian Power, Investor Relations
Exova Group plc
Telephone: +44 (0) 131 476 7612
About Exova
Exova is one of the world's leading laboratory-based testing
groups, trusted by organisations to test and advise on the safety,
quality and performance of their products and operations.
Headquartered in Edinburgh, UK, Exova operates 142 laboratories and
offices in 32 countries and employs around 4,500 people throughout
Europe, the Americas, the Middle East and Asia/Asia Pacific.
Exova's capabilities help to extend asset life, bring
predictability to applications, and shorten the time to market for
customers' products, processes and materials. With over 90 years'
experience, Exova specialises in testing across a number of key
sectors from health sciences to aerospace, transportation, oil and
gas, fire and construction.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASEEFWWFISELA
(END) Dow Jones Newswires
August 28, 2015 02:02 ET (06:02 GMT)
Exova (LSE:EXO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exova (LSE:EXO)
Historical Stock Chart
From Jul 2023 to Jul 2024